Fotticchia Iolanda, Guarnieri Daniela, Fotticchia Teresa, Falanga Andrea Patrizia, Vecchione Raffaele, Giancola Concetta, Netti Paolo Antonio
Dipartimento di Farmacia, Università di Napoli Federico II, via Domenico Montesano 49, 80131 Naples, Italy.
Istituto Italiano di Tecnologia (IIT)@CRIB, Largo Barsanti e Matteucci 53, 80125 Naples, Italy.
Colloids Surf B Biointerfaces. 2016 Aug 1;144:250-256. doi: 10.1016/j.colsurfb.2016.04.018. Epub 2016 Apr 8.
Targeted therapies represent a challenge in modern medicine. In this contest, we propose a rapid and reliable methodology based on Isothermal Titration Calorimetry (ITC) coupled with confluent cell layers cultured around biocompatible templating microparticles to quantify the number of overexpressing receptors on cell membrane and study the energetics of receptor-ligand binding in near-physiological conditions. In the in vitro model here proposed we used the bEnd3 cell line as brain endothelial cells to mimic the blood brain barrier (BBB) cultured on dextran microbeads ranging from 67μm to 80μm in size (Cytodex) and the primary human umbilical vein cells (HUVEC) for comparison. The revealed affinity between transferrin (Tf) and transferrin receptor (TfR) in both systems is very high, Kd values are in the order of nM. Conversely, the value of TfRs/cell reveals a 100-fold increase in the number of TfRs per bEnd3 cells compared to HUVEC cells. The presented methodology can represent a novel and helpful strategy to identify targets, to address drug design and selectively deliver therapeutics that can cross biological barriers such as the blood brain barrier.
靶向治疗是现代医学面临的一项挑战。在这种情况下,我们提出了一种快速可靠的方法,该方法基于等温滴定量热法(ITC),并结合在生物相容性模板微粒周围培养的汇合细胞层,以量化细胞膜上过表达受体的数量,并研究近生理条件下受体-配体结合的能量学。在本文提出的体外模型中,我们使用bEnd3细胞系作为脑内皮细胞来模拟血脑屏障(BBB),将其培养在尺寸范围为67μm至80μm的葡聚糖微珠(Cytodex)上,并使用原代人脐静脉细胞(HUVEC)进行比较。在这两个系统中,转铁蛋白(Tf)和转铁蛋白受体(TfR)之间显示出的亲和力非常高,解离常数(Kd)值处于纳摩尔级别。相反,与HUVEC细胞相比,每个bEnd3细胞中TfR的数量显示出增加了100倍。所提出的方法可以代表一种新颖且有用的策略,用于识别靶点、指导药物设计以及选择性地递送能够跨越血脑屏障等生物屏障的治疗药物。